Successful treatment of severe cytomegalovirus retinitis with foscarnet and intraocular injection of ganciclovir in a myelosuppressed unrelated bone marrow transplant patient.
A female patient with ALL received a bone marrow transplant (BMT) from an unrelated donor with a one locus HLA mismatch. The donor was heterozygous at the HLA-A locus, while the patient was homozygous at this locus. The patient had cytomegalovirus (CMV) antigenemia on day 42 following an intensive preparative regimen that included anti-thymocyte globulin and BU+CY+TBI to prevent graft rejection. Ganciclovir was given initially for the treatment of CMV antigenemia, although the patient soon developed severe myelosuppression. The patient's hematopoietic recovery was poor, and CMV and human herpesvirus-6 (HHV-6) were detectable in the peripheral blood. Severe CMV retinitis was treated with foscarnet and the intraocular injection of ganciclovir. The CMV retinitis improved and the marrow gradually recovered. CMV and HHV-6 were no longer detectable in the peripheral blood. Foscarnet and intraocular injection of ganciclovir appeared to be an effective treatment for CMV retinitis in this myelosuppressed BMT patient.
Okamoto
T
T
Second Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Okada
M
M
Mori
A
A
Saheki
K
K
Takatsuka
H
H
Wada
H
H
Tamura
A
A
Fujimori
Y
Y
Takemoto
Y
Y
Kanamaru
A
A
Kakishita
E
E
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D001082:Aqueous Humor; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy* / Q000635:transmission; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015552:Injections, Intralesional; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000628:therapy
D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir